[1］FDA网上公告［EB/OL］.http://www.fda.gov/cder/da/dal 1000.htm.2000，10.5. [2］Shulman LP. Expanding Contraceptive Choices: Lunelle monthly contraceptive injection［J］.Int J Fertil Womens Med,2000, 45(2):190. [3］Phillips OP. New aspects of injectable contraception ［J］.Int J Fertil Womens Med,2001, 46(1):31. [4］Sang GW, Shao QX, Ge RS,et al. A multicentred phase Ⅲ comparative clinical trial of Mesigyna, Cyclofem and injectable No 1 given monthly bintramuscular injection to Chinese women. Ⅰ. Contraceptive efficacy and side effects ［J］.Contraception,1995,51(3):167. [5］Kaunitz AM.Long-acting hormonal contraception; assessing impact on bone density, weight and mood［J］.Int J Fertil Womens Med,1999, 44(2):110. [6］Von Kesseru E, Etchepareborda JJ, Wikinski R,et al.Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns ［J］.Contraception,2000,61(5):317.